Antibiotics to prevent infections during blood cancer treatment
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether giving a preventive antibiotic during chemotherapy can lower the risk of infections in people with certain blood cancers. It may help reduce hospital stays and improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood cancer called myelodysplastic syndrome, a related blood disorder, or acute myeloid leukemia.
- You are about to start a type of chemotherapy called a hypomethylating agent.
- You have not had a fever or infection in the last month.
- You have not had a C. difficile infection in the last year.
- You are not allergic to fluoroquinolone antibiotics, and you do not have a history of tendon problems from them.
- You do not have a seizure disorder or myasthenia gravis.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tranexamic acid, a medicine that helps blood clot, can reduce bleeding in people with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who have very low platelet counts and are receiving less-intensive chemotherapy.
This trial tests whether an antibiotic called dalbavancin, given to prevent bacterial infections during chemotherapy-induced low white blood cell counts, is safe and works in children and young adults with certain types of leukemia. It may help reduce the risk of serious infections during treatment.
This trial tests whether using a targeted antifungal medicine (aimed at PTX3) can better prevent serious fungal infections in adults with AML or a related bone marrow disease who will have very low neutrophils. It may help lower the risk of dangerous infections during intensive chemotherapy hospital stays.
This study looks at certain proteins in the blood (called FLT3 ligand and IL6) of people being treated for blood cancers like AML, MDS, or CMML. The goal is to understand how these proteins change during non-intensive chemotherapy, which may help doctors better personalize treatment.
This early-phase trial tests whether a combination of targeted medicines can improve outcomes in people with higher-risk MDS or certain types of AML or CMML. It’s designed to find the safest dose and learn if the treatment can help the cancer respond.
This trial tests whether a single antibiotic (amoxicillin-clavulanate) works as well as taking two antibiotics (amoxicillin-clavulanate plus ciprofloxacin) for fever caused by chemotherapy in people with certain blood cancers. The goal is to treat the fever at home, avoiding a hospital stay, while keeping you safe and comfortable.
Hear when a new Acute Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.